| Code | 9745C | ||||||||||
| MA number | 30/0380/18-S | ||||||||||
| Product Form: | tbl flm 14x25 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 30 - ANTIDEPRESSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.11.2018 |
| Validity: | 29.11.2023 |
| MA renewed: | Renewal application submitted |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Agomelatin Glenmark 25 mg_01.2021.docx
|
| SPC: |
SPC_Agomelatine Glenmark 25 mg_01.2020+1B_005.docx
|
| Safety feature | Yes |
| Data update: | 13.12.2018 |
